Business context and reporting period
The supplied filing is Tempur Sealy International, Inc.’s Form 10-K for the fiscal year ended December 31, 2018, filed February 25, 2019. This does not match the request metadata naming SOMNIGROUP INTERNATIONAL INC.; confirm the intended issuer. The filing reports full-year results and includes unaudited quarterly data, including fourth-quarter results.
Tempur Sealy develops, manufactures and sells bedding products, including TEMPUR-PEDIC, Sealy and Stearns & Foster, through North America and International segments. Wholesale represented 90.7% of 2018 sales; Direct represented 9.3%.
Financial performance and condition
| Metric | FY 2018 | FY 2017 |
|---|---|---|
| Net sales | $2,702.9 million | $2,700.6 million |
| Gross profit / margin | $1,120.7 million / 41.5% | $1,121.0 million / 41.5% |
| Operating income / margin | $256.3 million / 9.5% | $295.5 million / 10.9% |
| Net income attributable to Tempur Sealy | $100.5 million | $151.4 million |
| Diluted EPS | $1.82 | $2.77 |
| Operating cash flow, continuing operations | $207.5 million | $256.5 million |
| Capital expenditures | $73.6 million | $66.6 million |
| Cash and cash equivalents | $45.8 million | $41.1 million |
| Total debt outstanding | $1,653.8 million | $1,762.5 million |
Sales were essentially flat year over year, while GAAP operating income fell 13.3% and attributable net income fell 33.6%. Adjusted EBITDA, a non-GAAP measure, was $424.7 million, down 4.7%; adjusted net income was $163.0 million, down 9.0%, and adjusted diluted EPS was $2.96 versus $3.28. Adjusted results exclude items including discontinued operations, restructuring, customer-related and supply-chain transition costs; they are not GAAP measures.
North America sales declined 1.7% to $2,136.2 million; excluding Mattress Firm, sales increased 2.8%. International sales rose 7.6% to $566.7 million, or 5.6% on a constant-currency basis. North America gross margin declined 40 basis points to 38.5%; International rose 10 basis points to 52.5%.
Working capital was $136.4 million. The company generated $207.5 million of continuing operating cash flow, used $71.2 million in continuing investing activities and $107.0 million in continuing financing activities. The company had no revolving-credit borrowings and reported $476.8 million of revolver availability after letters of credit. Its credit-agreement net leverage ratio was 3.87x against a 5.00x covenant maximum; it reported compliance with all debt covenants.
Fourth-quarter 2018 net sales were $676.1 million, operating income $57.9 million, continuing-operations income $19.1 million and attributable net income $12.3 million. Fourth-quarter diluted EPS from continuing operations was $0.35.
Material changes versus the prior comparable period
- Operating income and margins weakened despite nearly unchanged sales. Management cited 2018 commodity inflation, unfavorable merchandising mix, new-product launch costs and higher general and administrative expenses.
- North America wholesale sales were affected by the termination of the Mattress Firm relationship in 2017 and declines among certain traditional bedding and department-store retailers. Direct sales grew, supported by store and e-commerce expansion.
- Bad-debt expense increased to $31.3 million from $9.8 million, including $21.2 million of charges to fully reserve specified iMS-related assets and other customer bankruptcy-related costs.
- Continuing operating cash flow fell $49.0 million, primarily due to changes in receivables, inventories and income taxes payable. Capital expenditures increased by $7.0 million.
- Total debt declined by $108.7 million. Interest expense increased to $92.3 million from $87.3 million, primarily because of higher rates on variable-rate debt.
- Latin American subsidiaries were divested or shifted to licensee arrangements; their results are presented as discontinued operations. The company reported a $17.8 million after-tax discontinued-operations loss in 2018, versus $30.9 million in 2017.
Outlook, commentary, risks and unusual items
- Management expected 2019 capital expenditures of approximately $70–$75 million and cash interest payments of approximately $80–$85 million. It forecast a 2019 effective tax rate of 26%–28%, a leverage target range of 3.0x–4.0x, and expected leverage to be within that range.
- Management anticipated first-half 2019 foreign-exchange headwinds of about $30 million to sales, $3 million to net income and $5 million to EBITDA. It expected gross-margin benefits from Tempur sales growth, pricing actions of approximately $30 million, product mix and Direct-channel expansion, partly offset by a possible decline in Sealy sales. Commodity inflation was not expected to be significant, but tariffs remained a risk.
- The 2018 Tempur product rollout pressured near-term performance through launch costs, temporary rollout delays and consumer substitution toward lower-priced Tempur models. Management expected launch-related factors to taper, while cautioning that 2019 performance depended substantially on launch success. New Tempur-Breeze and Stearns & Foster products were planned for 2019.
- In January 2019, customer iMS filed for Chapter 11. The company agreed to provide debtor-in-possession financing and submitted a stalking-horse bid to acquire certain iMS assets for an expected value of up to $26 million, subject to auction, court approval and other conditions; closing was not assured.
- The company settled litigation with Mattress Firm effective February 11, 2019, in exchange for mutual releases. The filing also describes a pending shareholder securities action and derivative suits; outcomes and potential losses were not estimable for those cases.
- The Danish tax matter remains a significant uncertainty. The company accrued approximately $130.0 million for tax and interest relating to 2001–2011 and $35.3 million for 2012–2018; negotiations under an IRS-SKAT advance pricing agreement cover 2012–2022. An adverse resolution could materially affect earnings or liquidity. The company also disclosed that SKAT’s asserted interest calculation exceeded its calculation by approximately $19.2 million.
- Other principal risks include competition and low-priced Chinese mattress imports, retailer financial distress, raw-material and tariff costs, interest-rate and currency exposure, pension underfunding, cybersecurity and privacy compliance, and execution of product launches. A 100-basis-point rise in variable borrowing rates was estimated to reduce pretax income by $5.4 million.
- The company adopted the new lease standard on January 1, 2019 and expected to recognize $195–$235 million of additional right-of-use assets and lease liabilities, with no material effect on earnings or cash flows. The 2018 adoption of revenue-recognition guidance reclassified royalty income into sales; management said adoption did not significantly affect the financial statements.
- Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting.
Important facts for investors to verify
- Confirm the issuer identity: the filing is for Tempur Sealy International, Inc., not SOMNIGROUP INTERNATIONAL INC.
- Review GAAP-to-non-GAAP reconciliations and the scale and recurrence of excluded charges, especially bad debt, restructuring and supply-chain transition costs.
- Track collections, retailer bankruptcies and the ultimate financial outcome of the iMS financing and proposed asset purchase.
- Monitor the Danish tax agreement process, accrued exposure, VAT refunds withheld and related cash deposits with SKAT.
- Assess debt maturities, variable-rate exposure, covenant headroom and whether cash generation supports debt reduction and planned capital spending.
- Evaluate whether new-product launches, pricing and Direct-channel growth offset retailer weakness, import competition and tariff or commodity pressures.